NCT03656328View on ClinicalTrials.gov

Supplementation With Lacobacillus Reuteri ATCC PTA 4659 in Patients Affected by Acute Uncomplicated Diverticulitis

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

April 1, 2018

Primary Completion Date

October 10, 2018

Study Completion Date

December 30, 2018

Conditions
Acute Diverticulitis
Interventions
DIETARY_SUPPLEMENT

Lactobacillus Reuteri 4659

supplementation with L. reuteri 4659 twice a day for 10 days during the standard antibiotic therapy

DIETARY_SUPPLEMENT

Placebo

supplementation with a Placebo capsule twice a day for 10 days during the standard antibiotic therapy

Trial Locations (1)

00168

Policlinico universitario agostino gemelli, Roma

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

NCT03656328 - Supplementation With Lacobacillus Reuteri ATCC PTA 4659 in Patients Affected by Acute Uncomplicated Diverticulitis | Biotech Hunter | Biotech Hunter